Summit Therapeutics (SMMT) EBIT Margin (2015 - 2022)
Summit Therapeutics (SMMT) recorded EBIT Margin of -10225.39% in FY2022, down 5461.10 percentage points from -4764.29% in FY2021.
Powered by 
Analysis
Summit Therapeutics (SMMT) EBIT Margin (2015 - 2022) Analysis & Trends
Starting with FY2017, Summit Therapeutics' EBIT Margin history includes 6 years.
- Annual EBIT Margin has a five-year change of -7964.89 percentage points (FY2017 to FY2022).
- The FY2022 figure is the lowest annual EBIT Margin in data going back to FY2017.
- Per Business Quant data, SMMT's EBIT Margin was -4764.29% in FY2021 (+1420.94 pp), -6185.23% in FY2020 (-2487.66 pp), -3697.58% in FY2019 and 9.44% in FY2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -7,700.00% |
| Jun 30, 2022 | -5,400.85% |
| Mar 31, 2022 | -8,863.20% |
| Dec 31, 2021 | -10,377.29% |
| Sep 30, 2021 | -1,488.62% |
| Jun 30, 2021 | -41,631.58% |
| Mar 31, 2021 | -8,814.06% |
| Dec 31, 2020 | -6,246.49% |
| Sep 30, 2020 | -9,359.67% |
| Jun 30, 2020 | -9,032.94% |
| Mar 31, 2020 | -6,409.72% |
| Dec 31, 2019 | -18,820.24% |
| Oct 31, 2019 | -6,205.65% |
| Sep 30, 2019 | -4,182.43% |
| Jul 31, 2019 | -13,157.94% |
| Mar 31, 2019 | -1,629.60% |
| Oct 31, 2018 | -1,385.04% |
| Jul 31, 2018 | 64.53% |
| Apr 30, 2018 | -170.08% |
| Dec 23, 2017 | 15,170.13% |
API Access
Summit Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();